Negative Pressure Wound Therapy Systems Market

• The leading Negative Pressure Wound Therapy Systems (NPWT) companies working in the Negative Pressure Wound Therapy Systems (NPWT) Market include 3M, Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mölnlycke Health Care AB, Talley Group Ltd., Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp, PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., Innovative Therapies, Genadyne, Cork Medical, LLC, and others.
• As per recent data from the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population.

Negative Pressure Wound Therapy Systems (NPWT) Market by Product Type (Conventional NPWT Devices, Single-Use NPWT Devices), Negative Pressure Wound Therapy Systems (NPWT) Market by Wound Type (Pressure Ulcers, Diabetic Ulcers, and Venous Ulcers), Negative Pressure Wound Therapy Systems (NPWT) Market by End-User (Hospitals, Specialty Clinics, and Others), and Negative Pressure Wound Therapy Systems (NPWT) Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic and acute wounds and increase in surgical procedures worldwide.

The negative pressure wound therapy systems market was valued at USD 3.35 billion in 2023, growing at a CAGR of 5.09% during the forecast period from 2024 to 2030, to reach 4.50 billion by 2030. The negative pressure wound therapy systems market is expanding rapidly due to the collective impact of rising chronic and acute wound prevalence such as diabetic ulcers and pressure sores, increasing surgical procedures, and the growing product launches and approvals by key negative pressure wound therapy systems companies which are expected to significantly drive the demand for negative pressure wound therapy systems from 2024 to 2030.

Negative Pressure Wound Therapy (NPWT) Systems Market Dynamics:

According to the latest data provided by Diabetes Feet Australia (DFA) (2022), in Australia, 300,000 individuals are at risk of developing diabetic foot disease (DFD) per 100,000 population, with 50,000 already living with the condition. Of these, 12,500 people have undergone diabetes-related amputations, and 1,000 are currently hospitalized due to DFD. Each year, 12 new diabetes-related amputations are performed per 100,000 population.

Additionally, according to recent data and stats provided by IDF Atlas Report (2022), in African countries, the rates of diabetic foot ulcers range from 10% to 30%, while the prevalence of lower limb amputations varies between 3% and 35%.

Diabetic foot ulcers are chronic wounds that often require specialized treatment and negative pressure wound therapy systems solutions. As the prevalence of these ulcers rises, there is a growing demand for products that can effectively manage these wounds. The therapy is applied to manage severe foot ulcers, enhance wound healing, and minimize the need for more invasive surgical interventions, by providing a controlled environment that promotes tissue repair, negative pressure wound therapy systems can significantly improve the quality of care for individuals with diabetic foot complications.

As per recent data from the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Finland recorded 15,870 surgical procedures per 100,000 population in the same year. In contrast, Hong Kong, China, had 1,735 surgical procedures per 100,000 population in 2023. In countries like Germany and Finland, which have high rates of surgical procedures, this is often integrated into post-operative care to promote healing and reduce complications. This therapy is particularly valuable in managing complex wounds, such as those resulting from surgeries, by applying controlled negative pressure to the wound area, which helps in removing exudate and stimulating tissue growth. 

Moreover, companies are amplifying their production of negative pressure wound therapy systems and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in April 2023, 3M announced the FDA clearance for its Veraflo therapy with two different dressings. The company had designed its negative pressure wound therapy (NPWT) dressings to hydromechanically remove non-viable tissue. The Veraflo products provided clinically proven therapy that could reduce the number of required surgical debridements. By doing so, they prepared the wound for closure more quickly and helped reduce the length of stay and therapy.

Therefore, all the factors stated above collectively will drive the overall negative pressure wound therapy systems market during the forecast period from 2024 to 2030.

However, complications associated with NPWT systems such as wound dehiscence or damage to surrounding tissues and risk of infection, if not managed properly may act as key constraints limiting the growth of the negative pressure wound therapy systems market.

Negative Pressure Wound Therapy Systems Market Segment Analysis:

Negative Pressure Wound Therapy Systems Market by Product Type (Conventional NPWT Devices, Single-Use NPWT Devices), Negative Pressure Wound Therapy Systems (NPWT) Market by Wound Type (Pressure Ulcers, Diabetic Ulcers, and Venous Ulcers), Negative Pressure Wound Therapy Systems (NPWT) Market by End-User (Hospitals, Specialty Clinics, and Others), and Negative Pressure Wound Therapy Systems (NPWT) Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of negative pressure wound therapy systems, the single-use NPWT Devices category is expected to have a significant revenue share in the year 2023. This is because single-use negative pressure wound therapy offers several key features and advantages that enhance wound care management. One of the benefits is their convenience and ease of use, as these devices come pre-assembled and ready for immediate application, eliminating the need for complex setup and maintenance.

This streamlined approach reduces the risk of infection and simplifies the treatment process for healthcare providers. Additionally, single-use NPWT devices are designed to be compact and portable, making them ideal for use in a variety of settings, including outpatient clinics and home care environments. Their disposable nature also minimizes the risk of cross-contamination and eliminates the need for time-consuming cleaning and reprocessing.

Moreover, a new development in the dressing product lines and new product launches are bolstering the category growth of the negative pressure wound therapy systems market. For instance, in January 2022, Smith & Nephew plc added new indications for its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker’s systems for reducing the incidence of both deep and superficial incisional surgical sites and dehiscence. The Pico 7Y system, which treated two wounds simultaneously, was also cleared to aid in the reduction of the incidence of superficial incisional SSIs for high-risk patients in class I wounds post-operative seroma, and dehiscence.

Therefore, owing to the above-mentioned factors, the demand for the dressing category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the negative pressure wound therapy systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall negative pressure wound therapy systems market:

Among all the regions, North America negative pressure wound therapy systems market is expected to dominate the negative pressure wound therapy systems market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is driven by the increasing instances of traumatic brain injury and surgical procedures, rising cases of diabetes leading to amputation, and advancement in negative pressure wound therapy systems, regulatory support, and the introduction of innovative products by negative pressure wound therapy systems companies are anticipated to significantly propel market growth for negative pressure wound therapy systems from 2024 to 2030.

As per the American Society for Biochemistry and Molecular Biology in the year 2021, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. The above-mentioned source further stated that about 2.8 million people suffer from traumatic brain injury each year in the United States from which 2, 80,000 people result in hospitalizations. Also as per the recent data provided by the World Bank Group, in 2021, approximately 6,928 surgical procedures were performed per 100,000 population in Canada. Negative pressure wound therapy systems play a significant role in managing complex wounds that often accompany severe brain injuries and traumatic incidents. This advanced treatment method involves applying a controlled negative pressure to the wound area, which helps to remove excess fluid, reduce swelling, and promote faster healing. In the context of traumatic brain injuries, where wounds may be extensive and prone to complications, it aids in maintaining a clean and optimal environment for wound repair.

As per the recent data provided by the Centre for Disease Control and Prevention (2024), in 2021, 38.4 million people of all age groups or 11.6% of the U.S. population had diabetes. Further, as per the same source, 80% of Lower-limb amputations (LLAs) are a result of complications from diabetes. Negative pressure wound therapy systems are often employed in the management of wounds associated with diabetes, particularly in cases where complications can lead to lower-limb amputations. This advanced therapy uses a vacuum dressing to promote wound healing by drawing out excess fluid and reducing edema, which can be crucial for diabetic patients experiencing chronic or difficult-to-heal wounds. 

Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the negative pressure wound therapy systems market. For instance, in July 2024, AOTI’s NEXA negative pressure wound therapy system received 510(k) clearance from the US Food and Drug Administration (FDA), which extended its indications of use. Following the FDA clearance, the label of the Ireland-headquartered device company’s NPWT system was updated to include acute, extended, and home care settings, allowing it to be marketed for care sites, including home care settings, in the US.

In addition to this, in August 2021, Aatru Medical, LLC announced the US Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The FDA-cleared miniaturized device is designed to help heal open wounds after surgery by sealing and holding them shut using gentle suction.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the negative pressure wound therapy systems market.

Negative Pressure Wound Therapy Systems Companies:

Some of the key negative pressure wound therapy systems companies operating in the negative pressure wound therapy systems market include 3M, Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mölnlycke Health Care AB, Talley Group Ltd., Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp, PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., Innovative Therapies, Genadyne, Cork Medical, LLC, and others.

Recent Developmental Activities in the Negative Pressure Wound Therapy Systems Market:

• In April 2024, Smith & Nephew PLC launched its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US. The NPWT System was designed to enhance home-based care for patients with chronic wounds, including ulcers. Lightweight, compact, and discreet, the system could be easily carried or worn, operated quietly, and featured a canister.
• In April 2024, Smith & Nephew PLC announced the publication of a study demonstrating that its ALLEVYN LIFE foam dressing featured a novel mechanism of action for pressure injury prevention (PIP). The study revealed that the ALLEVYN LIFE foam dressing had layers capable of sliding independently, which absorbed mechanical energy that might otherwise have harmed the patient. This sliding action reduces pressure on the skin and underlying tissues.
• In April 2021, Joerns Healthcare and Medela announced a nationwide partnership to develop access to innovative negative pressure wound therapy systems. Through this agreement, Joerns expanded its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.

Key Takeaways from the Negative Pressure Wound Therapy Systems Market Report Study

• Negative Pressure Wound Therapy Systems Market size analysis for current negative pressure wound therapy systems market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key Negative Pressure Wound Therapy Systems product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key Negative Pressure Wound Therapy Systems companies dominating the negative pressure wound therapy systems market
• Various opportunities available for the other competitors in the Negative Pressure Wound Therapy Systems market
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current negative pressure wound therapy systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for negative pressure wound therapy systems market growth in the coming future?

Target audience who can be benefited from this Negative Pressure Wound Therapy Systems Market Report:

• Negative pressure wound therapy system product providers
• Research organizations and consulting companies 
• Negative pressure wound therapy systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in negative pressure wound therapy systems 
• Various end-users who want to know more about the negative pressure wound therapy systems market and the latest developments in the negative pressure wound therapy systems market

Get detailed insights @ DelveInsight Blogs